MSRV/HERV-W/syncytin and its linkage to multiple sclerosis: The usability and the hazard of a human endogenous retrovirus

Journal of NeuroVirology

Volumn 11, Issue 2, 2005, Pages 232-235

  Dolei, Antonina ^a  

^a UNIVERSITY OF SASSARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GENE PRODUCT; HUMAN ENDOGENOUS RETROVIRUS W PROTEIN; INTERLEUKIN 12P40; INTERLEUKIN 6; MULTIPLE SCLEROSIS ASSOCIATED RETROVIRUS PROTEIN; SYNCYTIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIRUS DNA;

ANTIGENICITY; ARTICLE; CELL STIMULATION; CELLULAR IMMUNITY; CHROMOSOME 14Q; CHROMOSOME 7Q; CYTOKINE PRODUCTION; DISEASE COURSE; DISEASE SEVERITY; GENETIC SUSCEPTIBILITY; GENOME; GENOME ANALYSIS; HERPES VIRUS; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; IN VITRO STUDY; IN VIVO STUDY; MULTIPLE SCLEROSIS; NEUROTROPISM; PERIPHERAL BLOOD MONONUCLEAR CELL; PERSISTENT VIRUS INFECTION; PLACENTA; PREGNANCY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RETROVIRUS; RISK ASSESSMENT; SCHIZOPHRENIA; T LYMPHOCYTE; UPREGULATION; VIRION; VIRUS DETECTION; VIRUS EXPRESSION; VIRUS REACTIVATION; VIRUS REPLICATION; VIRUS TRANSMISSION;

ANIMALS; CHROMOSOMES, HUMAN, PAIR 7; ENDOGENOUS RETROVIRUSES; GENE PRODUCTS, ENV; HUMANS; MICE; MULTIPLE SCLEROSIS; PREGNANCY PROTEINS; RETROVIRIDAE INFECTIONS;

DNA VIRUSES; HERPESVIRIDAE; HUMAN ENDOGENOUS RETROVIRUS; HUMAN ENDOGENOUS RETROVIRUS W; MULTIPLE SCLEROSIS ASSOCIATED RETROVIRUS;

EID: 20744446756     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.1080/13550280590952899     Document Type: Article

References (34)

1. Mi S, Lee X, Li X, Veldman GM, Finnerty H, Racie L, LaVallie E, Tang XY, Edouard P, Howes S, Keith JC Jr, McCoy JM (2000). Syncytin is a captive retroviral envelope protein involved in human placental morphogenesis. Nature 403: 785-789.
2. Muir A, Lover A, Moffett A (2004). Expression and functions of human endogenous retroviruses in the placenta: an update. Placenta 26: S16-S25.
3. Blond JL, Beseme F, Duret L, Benton O, Bedin F, Perron H, Mandrand B, Mallet F (1999). Molecular characterisation and placental expression of HERV-W, a new human endogenous retrovirus family. J Virol 73: 1175-1185.
4. Tristem M (2000). Identification and characterization of novel human endogenous retrovirus families by phylogenetic screening of the human genome mapping project database. J Virol 74: 3715-3730.
5. Blaise S, de Parseval N, Benit L, Heidmann T (2003). Genomewide screening for fusogenic human endogenous retrovirus envelopes identifies syncytin 2, a gene conserved on primate evolution. Proc Natl Acad Sci USA 100: 13013-13018.
6. Wei S, Charmley P, Concannon P (1995). DNA sequence and polymorphism analysis of a region of the T-cell receptor beta locus thought to contain a susceptibility gone for multiple sclerosis. Ann N Y Acad Sci 756: 307-309.
7. Villesen P, Aagaard L, Wiuf C, Pedersen FS (2004). Identification of endogenous retroviral reading frames in the human genome. Retrovirology 1: 32-.
8. Pavlicek A, Paces J, Elleder D, Hejnar J (2002). Processed pseudogenes of human endogenous retroviruses generated by LINEs: their integration, stability, and distribution. Genome Res 12: 391-399.
9. Kalter SS, Helmke RJ, Heberling RL, Panigel M, Fowler AK, Strickland JE, Hellman A (1973). C-type particles in normal human placentas. J Natl Cancer Inst 50: 1081-1084.
10. Villareal LP (1997). On viruses, sex, and motherhood. J Virol 71: 859-865.
11. Rote NS, Chakrabarti S, Stetzer BP (2004). The role of human endogenous retroviruses in trophoblast differentiation and placental development. Placenta 25: 673-683.
12. Stoye JP, Coffin JM (2000). A provirus put to work. Nature 403: 715-717.
13. Perron H, Geny C, Laurent A, Mouriquand C, Pellat J, Perret J, Seigneurin JM (1989). Leptomeningeal cell line from multiple sclerosis with reverse transcriptase activity and viral particles. Res Virol 140: 551-561.
14. Komurian-Pradel F, Paranhos-Baccala G, Bedin F, Ounanian-Paraz A, Sodoyer M, Ott C, Rajoharison A, Garcia E, Mallet F, Mandrand B, Perron H (1999). Molecular cloning and characterization of MSRV-related sequences associated with retrovirus-like particles. Virology 260: 1-9.
15. Perron H, Carson JA, Bedin F, Beseme F, Paranhos-Baccala G, Komurian-Pradel F, Mallet F, Tuke PW, Voisset C, Blond JL, Lalande B, Seigneurin JM, Mandrand B (1997). Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis. The Collaborative Research Group on Multiple Sclerosis. Proc Natl Acad Sci USA 94: 7583-7588.
16. Garson J, Tuke PW, Giraud P, Paranhos-Baccala G, Perron H (1998). Detection of virion-associated MSRV-RNA in serum of patients with multiple sclerosis. Lancet 351: 33.
17. Dolei A, Serra C, Mameli G, Pugliatti M, Sechi S, Cirotto MC, Rosati G, Sotgiu S (2002). Multiple sclerosis-associated retrovirus (MSRV) in Sardinian MS patients. Neurology 58: 471-473.
18. Nowak J, Januszkiewicz D, Pernak M, Liwe'n I, Zawada M, Rembowska J, Nowicka K, Lewandowski K, Hertmanowska H, Wender M (2003). Multiple sclerosis-associated virus-related pol sequences found both in multiple sclerosis and healthy donors are more frequently expressed in multiple sclerosis patients. J Neurovirol 9: 112-117.
19. Karlsson H, Schroeder J, Bachmann S, Bottmer C, Yolken RH (2004). HERV-W-related RNA detected in plasma from individuals with recent-onset schizophrenia or schizoaffective disorder. Molecular Psychiatry 9: 12-13.
20. Sotgiu S, Serra C, Mameli G, Pugliatti M, Rosati G, Arru G, Dolei A (2002). Multiple sclerosis (MS)-associated retrovirus and MS prognosis: an observational study. Neurology 59: 1071-1073.
21. Perron H, Firouzi R, Tuke P, Garson JA, Michel M, Beseme F, Bedin F, Mallet F, Marcel E, Seigneurin JM, Mandrand B (1997). Cell cultures and associated retroviruses in multiple sclerosis. Collaborative Research Group on MS. Acta Neurol Scand Suppl 169: 22-31.
22. Menard A, Amouri R, Michel M, Marcel F, Brouillet A, Belliveau J, Geny C, Deforges L, Malcus-Vocanson C, Armstrong M, Lyon-Caen O, Mandrand B, Dobransky T, Rieger F, Perron H (1997). Gliotoxicity, reverse transcriptase activity and retroviral RNA in monocyte/macrophage culture supernatants from patients with multiple sclerosis. FEBS Letters 413: 477-485.
23. Perron H, Jouvin-Marche E, Michel M, Ounanian-Paraz A, Camelo S, Dumon A, Jolivet-Reynaud C, Marcel F, Souillet Y, Borel E, Gebuhrer L, Santoro L, Marcel S, Seigneurin JM, Marche PN, Lafon M (2001). Multiple sclerosis retrovirus particles and recombinant envelope trigger an abnormal immune response in vitro, by inducing polyclonal Vbeta16 T-lymphocyte activation. Virology 287: 321-332.
24. Serra C, Mameli G, Arru G, Sotgiu S, Rosati G, Dolei A (2003). In vitro modulation of the multiple sclerosis (MS)-associated retrovirus (MSRV) by cytokines: implications for MS pathogenesis. J Neurovirol 9: 1-7.
25. Firouzi R, Rolland A, Jouvin-Marche E, Michel EM, Hauw JJ, Malcus-Vocanson JC, Lazarini F, Gebuhrer L, Seigneurin JL, Touraine JL, Marche PN, Sanhadji K, Perron H (2003). Multiple sclerosis associated retrovirus particles cause T-lymphocyte dependent death with brain hemorrage in humanized SCID mice model. J Neurovirol 9: 79-93.
26. Antony JM, Van Marle G, Opii W, Butterfield DA, Mallet F, Yong VW, Wallace JL, Deacon RM, Warren K, Power C (2004). Human endogenous retrovirus glycoprotein-mediated induction of redox reactants causes oligodendrocyte death and demyelination. Nat Neurosci 7: 1088-1095.
27. Johnston JB, Silva C, Holden J, Warren KG, Clark AW, Power C (2001). Monocyte activation and differentiation augment human endogenous retrovirus expression: implications for inflammatory brain diseases. Ann Neurol 50: 434-442.
28. Rolland A, Jouvin-Marche E, Saresella M, Ferrante P, Cavaretta R, Cre'ange A, Marche P, Perron H (2004). Correlation between disease severity and in vitro cytokine production mediated by MSRV (Multiple Sclerosis associated RetroViral element) envelope protein in patients with multiple sclerosis. J Neuroimmunol xxx-xxx, in press, PUBLISHED ON LINE.
29. Christensen T, Dissing Sorensen P, Riemann H, Hansen HJ, Munch M, Haahr S, Moller-Larsen A (2000). Molecular characterization of HERV-H variants associated with multiple sclerosis. Acta Neurol Scand 101: 229-238.
30. Perron H, Perin JP, Rieger F, Alliel PM (2000). Particle-associated retroviral RNA and tandem RGH/HERV-W copies on human chromosome 7q: possible components of a 'chain-reaction' triggered by infectious agents in multiple sclerosis? J Neurovirol 6 Suppl 2: S67-75.
31. Moore FGA, Wolfson C (2002). Human herpes virus and multiple sclerosis. Acta Neurol Scand 106: 63-83.
32. Lafon M, Jouvin-Marche E, Marche PN, Perron H (2002). Human viral superantigens: to be or not to be transactivated? Trends Immunol 23: 238-239.
33. Perron H, Suh M, Lalande B, Gratacap B, Laurent A, Stoebner P, Seigneurin JM (1993). Herpes simplex virus ICP0 and ICP4 immediate early proteins strongly enhance expression of a retrovirus harboured by a leptomeningeal cell line from a patient with multiple sclerosis. J Gen Virol 74: 65-72.
34. Brudek T, Christensen T, Hansen HJ, Bobecka J, Moller-Larsen A (2004). Simultaneous presence of endogenous retrovirus and herpes virus antigens has profound effect on cell-mediated immune responses: implications for multiple sclerosis. AIDS Res Hum Retroviruses 20: 415-423.